FDA Approves Maintenance Lenalidomide for Multiple Myeloma
The FDA has expanded the approval of lenalidomide to include its use as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Ian Ingram Tags: Hematologic Malignancies Multiple Myeloma News Source Type: news
More News: Cancer & Oncology | Hematology | Myeloma | Revlimid | Stem Cell Therapy | Stem Cells | Transplants